Ra Medical Systems adds clinical, sales representatives

Ra Medical Systems announces that additional representatives have been hired to support its VIVO technology in new territories within the United States. VIVO, developed by Ra Medical’s wholly owned subsidiary Catheter Precision, is a proprietary AI system used to non-invasively identify the origin of ventricular arrhythmias prior to an ablation procedure. To date, VIVO has only been available to select physicians as part of a limited launch. Hiring additional support, in increments by territories, is a part of the launch strategy established by Catheter Precision to ensure positive clinical adoption and an increase in utilization in 2023.